Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015057
Filing Date
2025-05-30
Accepted
2025-05-30 19:29:26
Documents
2
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 form4-05302025_110521.html 4  
1 form4-05302025_110521.xml 4 4084
2 ex24-05302025_110521.htm EX-24 6489
  Complete submission text file 0001415889-25-015057.txt   12100
Mailing Address C/O ATARA BIOTHERAPEUTICS, INC. 611 GATEWAY BLVD. #900 SOUTH SAN FRANCISCO CA 94080
Business Address
Porter Derrell (Reporting) CIK: 0001706400 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 251012782

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)